May, M. S., Park, H., Moallem, D. H., Seeram, D., Dajiang, S., Hibshoosh, H., Jamison, J. K., Uhlemann, A.-C., & Manji, G. A. (2024). Low Bacterial Biomass in Human Pancreatic Cancer and Adjacent Normal Tissue. International Journal of Molecular Sciences, 26(1), 140. https://doi.org/10.3390/ijms26010140

Jeong, M.-S., Baek, S.-W., Yang, G.-E., Mun, J.-Y., Kim, J. A., Kim, T.-N., Nam, J.-K., Choi, Y.-H., Lee, J.-S., Chu, I.-S., & Leem, S.-H. (2025). Chemoresistance-motility signature of molecular evolution to chemotherapy in non-muscle-invasive bladder cancer and its clinical implications. Cancer Letters, 610, 217339. https://doi.org/10.1016/j.canlet.2024.217339

Ben-David, R., Tillu, N., Alerasool, P., Bieber, C., Ranti, D., Tolani, S., Eisenhauer, J., Chung, R., Lavallée, E., Waingankar, N., Attalla, K., Wiklund, P., Mehrazin, R., Anderson, C. B., & Sfakianos, J. P. (2024). Induction and maintenance of sequential intravesical gemcitabine/docetaxel for intermediate and high-risk non-muscle invasive bladder cancer with different dosage protocols. World Journal of Urology, 42(1). https://doi.org/10.1007/s00345-024-04992-5